Perceptive Advisors - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,459,131
-38.4%
729,097
-9.8%
0.38%
-40.4%
Q3 2022$21,834,000
+176.0%
808,671
+41.2%
0.63%
+155.6%
Q2 2022$7,912,000
+195.0%
572,514
+316.3%
0.25%
+359.3%
Q1 2022$2,682,000
+66.8%
137,514
+108.9%
0.05%
+107.7%
Q2 2020$1,608,000
-88.3%
65,839
-92.9%
0.03%
-92.7%
Q1 2020$13,690,000
+2.8%
925,000
+12.8%
0.36%
+35.2%
Q4 2019$13,315,000
-30.2%
820,377
+32.5%
0.26%
-50.6%
Q1 2018$19,064,000
+33.3%
618,957
+54.7%
0.53%
+12.7%
Q4 2017$14,300,000400,0000.47%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,228,609$59,972,1455.67%
Essex Woodlands Management, Inc. 457,085$5,242,7654.62%
Ghost Tree Capital, LLC 350,000$4,014,5001.32%
AlphaCentric Advisors LLC 190,000$2,179,3001.24%
Sio Capital Management, LLC 342,477$3,928,2111.22%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 288,726$3,308,8001.12%
Rubric Capital Management LP 1,600,000$18,352,0000.69%
RICE HALL JAMES & ASSOCIATES, LLC 683,937$7,844,7570.50%
Rhenman & Partners Asset Management AB 361,679$4,148,4580.45%
Polar Capital Holdings Plc 4,160,311$47,718,7670.35%
View complete list of REVANCE THERAPEUTICS INC shareholders